{"id":61690,"date":"2025-08-05T16:05:26","date_gmt":"2025-08-05T14:05:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\/"},"modified":"2025-08-05T16:05:26","modified_gmt":"2025-08-05T14:05:26","slug":"sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\/","title":{"rendered":"SCH Capital Holdings, Inc. Adds Health Care Compensation Management Technology Capability to Portfolio"},"content":{"rendered":"
\n

CHICAGO–(BUSINESS WIRE)–#SCHCapitalHoldings<\/a>–SCH Capital Holdings, Inc., the nation\u2019s leading human capital information management holding company for health care and not-for-profit\/tax-exempt organizations, has acquired Boston-based Statera<\/a>.<\/p>\n

\nFormed in 2020, Statera is a group of human-focused compensation experts and health care technologists who provide timely and actionable compensation and care insights to hospitals, medical groups, and clinicians. Statera’s platform offers a comprehensive suite of tools that optimize clinical team performance and automate compensation administration.<\/p>\n

\nStatera will continue to enable health systems to automate physician compensation through its technology platform as part of Clinician Nexus<\/a>, a SCH Capital Holdings, Inc. technology company. Together, these combined capabilities will provide health care organizations with a broad mix of technology tools that empower health systems and medical groups to align compensation, productivity, and incentives for their physicians and APPs.<\/p>\n

\n\u201cWhen we combine Statera\u2019s focus on academic medical centers alongside Clinician Nexus\u2019s integrated delivery systems expertise, we are able to serve the entire health care marketplace with specialized compensation management expertise in both segments,\u201d said Ted Chien<\/a>, President and CEO of SCH Capital Holdings, Inc.<\/p>\n

\n\u201cWe are excited to join the SCH Capital Holdings, Inc., family and integrate our expertise into the Clinician Nexus brand,\u201d said Amy Jackson<\/a>, CEO of Statera. \u201cThe company\u2019s gold standard reputation and Clinician Nexus’s established platform will enable us to reach new markets. Together, we’ll be able to deliver the next generation of compensation management technology to a broader audience and make a greater impact across the health care ecosystem.\u201d<\/p>\n

\nAbout SCH Capital Holdings, Inc.<\/b><\/p>\n

\nSCH Capital Holdings, Inc., is the parent company of independent operating brands SullivanCotter<\/a>, Clinician Nexus<\/a>, Lotis Blue Consulting<\/a> and C3 Nonprofit Consulting Group<\/a>. This collection of complementary brands helps organizations solve complex workforce issues by enabling people, processes and technology aimed at large-scale business transformation.<\/p>\n

\nFor more information, email info@sullivancotter.com<\/a> or call 888.739.7039.<\/p>\n

\nNote to media:<\/i><\/b> Additional information and interviews are available on request.<\/i><\/p>\n

Contacts<\/b> <\/p>\n

\nBecky Lorentz
\n
Clinician Nexus\/SCH Services
\n
beckylorentz@cliniciannexus.com<\/a>
314.414.3719<\/p>\n

\nJenni Bowring
\n
Padilla
\n
jenni.bowring@padillaco.com<\/a>
651.226.3858<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CHICAGO–(BUSINESS WIRE)–#SCHCapitalHoldings–SCH Capital Holdings, Inc., the nation\u2019s leading human capital information management holding company for health care and not-for-profit\/tax-exempt organizations, has acquired Boston-based Statera. Formed in 2020, Statera is a group of human-focused compensation experts and health care technologists who provide timely and actionable compensation and care insights to hospitals, medical groups, and clinicians. Statera’s … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61690","6":"format-standard","7":"category-industry"},"yoast_head":"\nSCH Capital Holdings, Inc. Adds Health Care Compensation Management Technology Capability to Portfolio - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SCH Capital Holdings, Inc. Adds Health Care Compensation Management Technology Capability to Portfolio - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHICAGO–(BUSINESS WIRE)–#SCHCapitalHoldings–SCH Capital Holdings, Inc., the nation\u2019s leading human capital information management holding company for health care and not-for-profit\/tax-exempt organizations, has acquired Boston-based Statera. Formed in 2020, Statera is a group of human-focused compensation experts and health care technologists who provide timely and actionable compensation and care insights to hospitals, medical groups, and clinicians. Statera’s ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-05T14:05:26+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"SCH Capital Holdings, Inc. Adds Health Care Compensation Management Technology Capability to Portfolio\",\"datePublished\":\"2025-08-05T14:05:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\\\/\"},\"wordCount\":357,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\\\/\",\"name\":\"SCH Capital Holdings, Inc. Adds Health Care Compensation Management Technology Capability to Portfolio - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2025-08-05T14:05:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SCH Capital Holdings, Inc. Adds Health Care Compensation Management Technology Capability to Portfolio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SCH Capital Holdings, Inc. Adds Health Care Compensation Management Technology Capability to Portfolio - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\/","og_locale":"en_US","og_type":"article","og_title":"SCH Capital Holdings, Inc. Adds Health Care Compensation Management Technology Capability to Portfolio - Pharma Trend","og_description":"CHICAGO–(BUSINESS WIRE)–#SCHCapitalHoldings–SCH Capital Holdings, Inc., the nation\u2019s leading human capital information management holding company for health care and not-for-profit\/tax-exempt organizations, has acquired Boston-based Statera. Formed in 2020, Statera is a group of human-focused compensation experts and health care technologists who provide timely and actionable compensation and care insights to hospitals, medical groups, and clinicians. Statera’s ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\/","og_site_name":"Pharma Trend","article_published_time":"2025-08-05T14:05:26+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"SCH Capital Holdings, Inc. Adds Health Care Compensation Management Technology Capability to Portfolio","datePublished":"2025-08-05T14:05:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\/"},"wordCount":357,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\/","url":"https:\/\/pharma-trend.com\/en\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\/","name":"SCH Capital Holdings, Inc. Adds Health Care Compensation Management Technology Capability to Portfolio - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2025-08-05T14:05:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/sch-capital-holdings-inc-adds-health-care-compensation-management-technology-capability-to-portfolio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"SCH Capital Holdings, Inc. Adds Health Care Compensation Management Technology Capability to Portfolio"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61690"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61690\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}